Posts  / DXYZ  / #POST-237234
REDDIT

SqueezeFinder - April 15th 2026

S
Apr 15, 2026 · 11:23

https://preview.redd.it/g93jn2p99cvg1.png?width=1894&format=png&auto=webp&s=901399bcb2053bc1fadc10ea48e51a44f7bc9473

Good Morning SqueezeFinders,

It would seem the bulls are back with a reckoning, so assuming nothing sketchy interrupts this insane recovery for the broader market/$QQQ tech index, I would say it’s safe to assume continued cautiously optimistic approach, if not totally optimistic approach from the market. The $QQQ tech index closed yesterday at 628.60 (+1.82%), which leaves us significantly above the 613 bullish pivot, so bears are likely sweating bullets as we rocket back towards all-time highs at 635.80. Only sign we should shift back towards caution would be if we fall back below the pivot at 613. The main directional sentiment determinants for today are a mix of a few big earnings reports like $MS and $BAC in premarket, the below-detailed economic data releases, and also any continued developments in the Middle-East (I heard Trump will be on FOX to state the war is “nearing an end” today). Regardless of broader market sentiment, you can always locate relative strength by checking SqueezeRadar go track irregularities in our data, or check out our automated trading robot, SqueezeBot to get an edge on the market without having to stare at the screen all day long. We just released the results for the month of March for SqueezeBot, and it was a shocking winrate of 74.63%, average gain was \~2.29% per trade (fixed % profit-taking scalps enabled). We allow for 3%, 5%, or 10% fixed profit-taking parameters. Check out SqueezeBot today!

🥇 Gold: \~$4,830/oz (-0.3%)
🥈 Silver: \~$80/oz (+0.8%)
🪙 Bitcoin: \~$74.5k/coin (-0.1%)
🛢️ Oil: \~$91/barrel (-0.4%)

Today's economic data releases are:

🇺🇸 NY Empire State Manufacturing Index (Apr) @ 8:30AM ET
🇺🇸 Import Price Index (Mar) @ 8:30AM ET
🇺🇸 Export Price Index (Mar) @ 8:30AM ET
🇺🇸 Fed Vice Chair for Supervision Barr Speaks @ 8:30AM ET
🇺🇸 Crude Oil Inventories @ 10:30AM ET
🇺🇸 Cushing Crude Oil Inventories @ 10:30AM ET
🇺🇸 FOMC Member Bowman Speaks @ 1:45PM ET
🇺🇸 Beige Book @ 2:00PM ET

📙Breakdown point: BELOW this price, the move will lose momentum significantly in the short-term, as shorts will gain confidence encouraging them to short more. Reducing probability of a squeeze without a catalyst.

📙Breakout point: ABOVE this price, the move will gain momentum significantly in the short-term, as shorts losses will increase pressuring them to cover. Increasing the probability of a squeeze occurring, especially if with a catalyst.

4. $DXYZ
Squeezability Score: 49%
Juice Target: 89.1
Confidence: 🍊 🍊
Price: 30.10 (+0.33%)
Breakdown point: 28.0
Breakout point: 41.0
Mentions (30D): 3
Event/Condition: Q4 results showed strong NAV growth to $19.97 per share with portfolio expansion adding $127 million exposure to high-profile names like Anthropic plus new SpaceX IPO rumors driving investor enthusiasm for a potential massive June listing valued at over 1.75 trillion dollars creating immediate repricing opportunity for the fund's holdings + ongoing trading momentum positions the vehicle as premier indirect access to SpaceX and other elite private tech assets with liquidity catalysts on the horizon + sustained premium interest and volume spikes highlight market conviction in near-term upside from private market developments

5. $MLTX
Squeezability Score: 48%
Juice Target: 30.6
Confidence: 🍊 🍊
Price: 18.78 (+1.9%)
Breakdown point: 16.0
Breakout point: 19.8
Mentions (30D): 2
Event/Condition: Positive Week 40 Phase 3 data in hidradenitis suppurativa demonstrating 62 percent HiSCR75 response rate at the AAD meeting reinforcing the potential for best-in-class IL-17 inhibition with plans for BLA submission in the second half of 2026 + announcement of upcoming Capital Markets Day on April 29 providing detailed updates on regulatory path, clinical readouts and commercialization strategy for sonelokimab across multiple indications + sustained institutional buying momentum including increased stake by JPMorgan amid continued positive long-term efficacy signals from the nanobody platform + Recent price target 🎯 of $40 from Rothschild & Co + Recent price target 🎯 of $24 from Wolfe Research + Recent price target 🎯 of $30 from BTIG

Access our cutting-edge research tools, live watchlists, alerts, and more: [https://www.squeeze-finder.com/subscribe/](https://www.squeeze-finder.com/subscribe/)

Use code RDDT to get your first month for only $10